Promoter methylation of MCAM, ERα and ERβ in serum of early stage prostate cancer patientsMariana Brait(Johns Hopkins University), Mohammad Obaidul Hoque(Johns Hopkins University)OncotargetJanuary 28, 201710.18632/oncotarget.14873Cited by 38SaveCiteExport RISWatch citationsRelated PapersOGDHL Is a Modifier of AKT-Dependent Signaling and NF-κB Function|PLoS ONE|2012|70Association of Promoter Methylation of VGF and PGP9.5 with Ovarian Cancer Progression|PLoS ONE|2013|46An epigenetic marker panel for recurrence risk prediction of low grade papillary urothelial cell carcinoma (LGPUCC) and its potential use for surveillance after transurethral resection using urine|Oncotarget|2014|23Epigenetic Treatment Alters Immune-Related Gene Signatures to Increase the Sensitivity of Anti PD-L1 Drugs|Cancers|2025|1